| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +4.52M | 87% | $18.18 | +$82.2M |
| Sells | 5 | -674K | 13% | $32.67 | -$22M |
| Net | -1 | +3.85M | 74.1% | +$60.2M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | Director | $139M | +$47.5M | +51.8% | Sep 4, 2025 |
| Brian Taylor Slingsby | Director, 10%+ Owner | $120M | +$3.5M | +3% | Mar 13, 2025 |
| Srinivas Akkaraju | Director | $101M | +$23.1M | +29.5% | Sep 4, 2025 |
| Samsara BioCapital GP, LLC | 10%+ Owner | $76.6M | +$8.1M | +11.8% | Mar 13, 2025 |
| Jon Congleton | Chief Executive Officer, Director | $29.6M | -$10.3M | -25.8% | Nov 11, 2025 |
| HBM Healthcare Investments (Cayman) Ltd. | 10%+ Owner | $19.2M | Feb 14, 2023 | ||
| David Malcom Rodman | Chief Medical Officer | $3.06M | -$2.14M | -41.2% | Oct 15, 2025 |
| Adam Levy | CFO and Secretary | $909K | -$7.28M | -88.9% | Nov 11, 2025 |
| Alexander M. Gold | Director | $0 | -$1.58M | -100% | Nov 11, 2025 |
| Daphne Karydas | Director | $0 | -$690K | -100% | Nov 13, 2025 |
| Alexander Asam | Director | Feb 9, 2023 | |||
| Takeshi Takahashi | Director | Jul 12, 2023 | |||
| Olivier Litzka | Director | May 22, 2024 | |||
| Derek DiRocco | Director | Feb 13, 2025 | |||
| Glenn Sblendorio | Director | Feb 13, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|